SCI

Sickle Cell Disease (SCD)

Sickle Cell Disease (SCD)

Sickle Cell Disease – Sickle Cell Disease (SCD) is a group of hereditary blood disorders caused by a genetic inborn error of metabolism that affects hemoglobin, the molecule that delivers oxygen throughout the body via red blood cells. As a result, it has been found that sickle cell patients have abnormal blood fatty acids in red blood cells. These findings led naturally to the hypothesis that certain fatty acids may be useful in the treatment of SCD.

We are currently conducting a human clinical trial with the objective of showing that our SCI-4000 product candidate can moderate SCD by impacting the fatty acid balance in patients and correcting the metabolic disorder.